Literature DB >> 33469753

Trend of Non-contrast Chest Computed Tomography Use in the Lung Cancer Screening Era: SEER-Medicare 2008-2016.

Szu-Chun Yang1,2, Cary Gross3, Jung-Der Wang2,4, Shi-Yi Wang5,6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33469753      PMCID： PMC8606484          DOI： 10.1007/s11606-020-06586-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.

Authors:  Paul F Pinsky; David S Gierada; William Black; Reginald Munden; Hrudaya Nath; Denise Aberle; Ella Kazerooni
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

2.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.

Authors:  Ahmedin Jemal; Stacey A Fedewa
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

3.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

4.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391
  4 in total
  1 in total

1.  Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan.

Authors:  Szu-Chun Yang; Ching-Han Lai; Chin-Wei Kuo; Chien-Chung Lin; Wu-Wei Lai; Jung-Der Wang
Journal:  Int J Environ Res Public Health       Date:  2021-04-12       Impact factor: 3.390
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.